D. Melvin

Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men.

L. Ferrucci, M. Shardell, J. Egan, 2016, The Journal of clinical endocrinology and metabolism.

Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters

L. Ferrucci, M. Shardell, J. Egan, 2017, Andrology.

Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes

J. Egan, Wook Kim, Yu-Kyong Shin, 2009, Diabetes.

Exogenous glucose-dependent insulinotropic polypeptide worsens post- prandial hyperglycemia in type 2 diabetes Running title: GIP and hyperglycemia in type 2 diabetes

J. Egan, Wook Kim, Yu-Kyong Shin, 2009 .

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

J. Egan, D. Kapogiannis, R. Mullins, 2022, Cells.

Effects of transdermal testosterone gel or an aromatase inhibitor on serum concentration and pulsatility of growth hormone in older men with age-related low testosterone.

M. Shardell, J. Egan, O. Carlson, 2017, Metabolism: clinical and experimental.

Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized‐controlled trial

L. Ferrucci, E. Simonsick, M. Shardell, 2016, Andrology.